Recurrent phlyctenular keratoconjunctivitis: A forme fruste manifestation of rosacea

Optometry

Volumn 72, Issue 3, 2001, Pages 179-184

  Blaustein, Bernard H ^a   Gurwood, Andrew S ^a  

^a PENNSYLVANIA COLLEGE OF OPTOMETRY   (United States)

Author keywords

Children; Cornea; Inflammation; Keratoconjunctivitis; Phlyctenulosis; Rosacea; Staphylococcus

Indexed keywords

EYE DROPS; GLUCOCORTICOID;

ARTICLE; CASE REPORT; CHILD; CONJUNCTIVA; CORNEA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; KERATOCONJUNCTIVITIS; PATHOLOGY; RECURRENT DISEASE; ROSACEA;

CHILD; CONJUNCTIVA; CORNEA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; KERATOCONJUNCTIVITIS; OPHTHALMIC SOLUTIONS; RECURRENCE; ROSACEA;

EID: 0035291425     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Beauchamp G, Gillette TE, Friendly DS. Phlyctenular keratoconjunctivitis. J Pediatr Ophthalmol Strabismus 1981; 18:22-8.
2. Cullom RD, Chang B. Cornea: Phlyctenulosis. In: Cullom RD, Chang B, eds. The Will's eye manual: office and emergency room diagnosis and treatment of eye disease. Philadelphia: JB Lippincott. 1994:64-5 .
3. Wagoner MD, Bajart AM, Allansmith MR. Phlyctenulosis. In: Fraunfelder FT, Roy FH, eds. Current ocular therapy 3. Philadelphia: WB Saunders, 1990:454-6.
4. abu el-Asrar AM, Van den Oord JJ, Geboes K, et al. Phenotypic characterization of inflammatory cells in phlyctenular eye disease. Doc Ophthalmol 1988;70:353-62 .
5. McCulloch D, Alexander A. Phlyctenular keratoconjunctivitis. J Am Optom Assoc 1983;54:435-9.
6. Mondino BJ. Inflammatory diseases of the peripheral cornea. Ophthalmology 1988;95:463-72.
7. Koppert HC, van Rij G. The phlycten, a come-back? Doc Ophthalmol 1982;52:339-45.
8. Archila EA, Arenas MC. The etiopathology of pinguecula and pterygium. Cornea 1995;14:543-4.
9. Frucht-Pery J, Solomon A, Siganos CS, et al. Treatment of inflamed pterygium and pinguecula with topical indomethocin 0.1% solution. Cornea 1997;16:42-7.
10. Baum JL, Mishima S, Boruchoff A. On the nature of dellen. Arch Ophthalmol 1968;79:657-62.
11. Cullom RD, Chang B. Cornea: Infectious corneal ulcer/infiltrate. In: Cullom RD, Chang B, eds. The Will's eye manual: office and emergency room diagnosis and treatment of eye disease. Philadelphia: JB Lippincott, 1994:69-73.
12. Cullom RD, Chang B. Conjunctiva/sclera/external disease: Allergic conjunctivitis (e.g., hayfever). In: Cullom RD, Chang B, eds. The Will's eye manual: office and emergency room diagnosis and treatment of eye disease. Philadelphia: JB Lippincott, 1994:112.
13. Chalmers DA, Rosacea: recognition and management for the primary care provider. Nurse Pract 1997;22:18,23-8,30.
14. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea [Letter] Am J Gastroenterol 1994; 89:1603-4.
15. Utas S, Ozbakir O, Tursan A, et al. Helicobacter pylori erradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999;40:433-5.
16. Son SW, Kim OH, Kim JG. The response of rosacea to erradication of Helicobacter pylori [Letter]. Br J Dermatol 1999;140:984-5.
17. Jones M. Helicobacter pylori in rosacea: lack of an association. [Letter] Arch Dermatol 1998;134:511.
18. Bamford JT, Tilden RL, Blankush JL, et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999;135:659-63.
19. Sharma VK, Lynn A, Kaminski M, et al. A study of the prevalence of Helicobacter infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol 1998;93:220-2.
20. Browning DJ, Rosenwasser G, Lugo M. Ocular rosacea in blacks. Am J Ophthalmol 1986;101:441-4.
21. Rosen T, Stone MS. Acne rosacea in blacks. J Am Acad Dermatol 1987;17:70-3.
22. Zuber TJ. Rosacea. Prim Care 2000;27:309-18.
23. Akpek EK, Merchant A, Pinar V, et al. Ocular rosacea: patient characteristics and follow-up. Ophthalmology 1997;104:1863-7.
24. Kligman AM. Ocular rosacea: current concepts and therapy. Arch Dermatol 1997;133:89-90 .
25. Quarterman MJ, Johnson DW, Abele AC, et al. Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 1997; 133:49-54.
26. Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 1995;14:144-6 .
27. Brown SI, Shahinian L Jr. Diagnosis and treatment of ocular rosacea. Ophthalmology 1978;85:779-86.
28. Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol 1986;31:145-58 .
29. Yolton DP. Anti-infective drugs. In: Bartlett JD, Jaanus SD, eds. Clinical ocular pharmacology, 3rd ed. Boston: Butterworth-Heinemann, 1995:268-72 .
30. Aronson IK, Rumsfeld JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm 1987;21:346-51.
31. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole for rosacea. Arch Dermatol 1987;123:606-14 .
32. Schmadel LK, McEvoy GK. Topical metronidazole: a new therapy for rosacea. Clin Pharm 1990;9:94-101.
33. Barnhorst DA, Foster JA, Chern KC, et al. The efficacy of topical metronidazole in the treatment of ocular rosacea. Ophthalmology 1996;103:1880-3.
34. Culbertson WW, Huang AJ, Mandlebaum SH, et al. Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology 1993;100:1358-66.